$RGR

HR8297 is a bill introduced April 15, 2026, that would remove D.C.'s feature-based firearm bans, registration requirements, and concealed carry restrictions. It is in the earliest procedural stage — referred to two committees — with zero appropriations. The bill is not a market-moving catalyst at this stage. Pure-play firearm manufacturers SWBI and RGR would benefit structurally if enacted, but D.C. represents a negligible share of the U.S. firearms market.

S.3085 is an early-stage committee bill requiring continued NICS, ATF, and export licensing operations during government shutdowns. For firearm manufacturers like Ruger ($RGR) and Smith & Wesson ($SWBI), this removes a known operational risk but adds no new revenue. Both stocks are near 52-week highs with recent upward momentum, reflecting broader sector strength rather than this specific bill.

The SHUSH Act (S.345) is an early-stage bill that would deregulate firearm silencers at the federal level, removing NFA tax and registration requirements and preempting state restrictions. If enacted, this transforms silencers from a niche regulated accessory into a mainstream category addressable to all 20M annual firearm purchasers. Pure-play firearm manufacturers $RGR and $SWBI have already priced in anticipation (up 8.56% and 7.82% in 30 days, respectively), while ammunition/accessory maker $POWW has not yet moved.

S. 1531, the Assault Weapons Ban of 2025, is an early-stage Senate bill that would prohibit civilian manufacture, sale, and transfer of semiautomatic assault weapons. Pure-play firearm manufacturers $SWBI and $RGR face existential revenue risk if enacted, but the bill remains at the referral stage with no committee markup or floor vote scheduled. Market data shows a modest 7-8% climb over 30 days as gun buyers front-run potential restrictions.

HR7499 is a bill proposing CPSC jurisdiction over firearms safety standards. It is in early stage (referred to committee) with 33 Democratic cosponsors and faces long odds in the current Republican-controlled House. Sturm, Ruger ($RGR) and Smith & Wesson ($SWBI) are the most directly exposed pure-play manufacturers. Real market data shows both stocks near their 52-week highs, with $RGR at $43.09 (+7.46% 30-day) and $SWBI at $15.42 (+7.61% 30-day), reflecting no material market concern about the bill's passage.

The SHUSH Act (HR850) is a deregulatory bill that removes silencers from NFA and GCA regulation, eliminating the $200 tax stamp and state bans. This transforms silencers from regulated firearms into unregulated accessories, expanding the US suppressors TAM from ~$1B to potentially $3-5B. Primary beneficiaries are firearms manufacturers and accessory producers. The bill is in early legislative stages, but real market data shows leading pure-play stocks $SWBI and $RGR trading near 52-week highs with positive 7- and 30-day momentum, reflecting market anticipation of deregulation. Olin Corporation gains a smaller but real ammunition demand tailwind.

HR556 (Protecting Access for Hunters and Anglers Act) removes the threat of a federal ban on lead ammunition and tackle on most federal hunting and fishing lands. The bill has cleared the House Natural Resources Committee (amended), been discharged from Agriculture, and has 83 cosponsors and an identical Senate companion bill. $RGR and $OLN are direct beneficiaries — the bill protects their core ammunition revenue streams from a material regulatory downside risk.